| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/08/2009 | CA2690370A1 Modified globin proteins with altered electron transport pathway |
| 01/08/2009 | CA2686752A1 Stable double emulsions |
| 01/07/2009 | EP2012293A1 Method for marking materials |
| 01/07/2009 | EP2011874A1 Recombinant gelatin in vaccines |
| 01/07/2009 | EP2011835A1 A colouring composition comprising starch derivatives as a hydrocolloid |
| 01/07/2009 | EP2011565A1 Core/skin type capsules and preparation method |
| 01/07/2009 | EP2011526A2 Patch and patch preparation |
| 01/07/2009 | EP2011525A2 Patch and patch preparation |
| 01/07/2009 | EP2011519A1 Process and apparatus for preparing a diagnostic or therapeutic agent |
| 01/07/2009 | EP2011517A1 Polynucleotide binding complexes comprising sterols and saponin |
| 01/07/2009 | EP2011516A1 Method of producing polymer micelle having low molecular chemical encapsulated therein |
| 01/07/2009 | EP2011507A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 01/07/2009 | EP2011488A1 Transdermal patch containing rasagiline for treatment or prophylaxis of nervous system disease and its preparation process |
| 01/07/2009 | EP2011487A2 Pharmaceutical compositions for gastroinetestinal drug delivery |
| 01/07/2009 | EP2011486A1 Pharmaceutical compositions of rifaximin |
| 01/07/2009 | EP2011485A2 Once-a-day oxycodone formulations |
| 01/07/2009 | EP2011484A2 Use of a dry powder composition of formoterol in the treatment of chronic obstructive pulmonary disease |
| 01/07/2009 | EP2011482A1 Solid preparation for oral application |
| 01/07/2009 | EP2011467A1 Fluid container and airless fluid dispensing system |
| 01/07/2009 | EP2011452A1 Injectable preparation for a muscle implant |
| 01/07/2009 | EP2010499A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns |
| 01/07/2009 | EP2010366A2 Process for the preparation of a hot-melt extruded laminate |
| 01/07/2009 | EP2010239A2 Water resistant film forming compositions incorporating hydrophilic activities |
| 01/07/2009 | EP2010191A2 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
| 01/07/2009 | EP2010190A2 Pharmaceutical solution formulations for pressurised metered dose inhalers |
| 01/07/2009 | EP2010189A2 Osmotic drug delivery system comprising release enhancing agent |
| 01/07/2009 | EP2010184A2 Implants for the treatment of dopamine associated states |
| 01/07/2009 | EP2010162A1 Drug delivery composition |
| 01/07/2009 | EP2010161A2 Oral dosage formulations and methods of preparing the same |
| 01/07/2009 | EP2010160A2 Bulking of soft tissue |
| 01/07/2009 | EP2010159A1 Fast release paracetamol tablets |
| 01/07/2009 | EP2010158A1 Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix |
| 01/07/2009 | EP2010157A1 Crush-resistant oxycodone tablets intended for preventing accidental misuse and unlawful diversion |
| 01/07/2009 | EP2010156A2 Stabilized compositions containing alkaline labile drugs |
| 01/07/2009 | EP2010155A2 Glucagon-like peptide 1(glp-1) pharmaceutical formulations |
| 01/07/2009 | EP2010154A2 Mask-tasting solid preparation of pioglitazone |
| 01/07/2009 | EP2010153A2 Drug microparticles |
| 01/07/2009 | EP2010152A1 Magnetic nanoparticles compositions and uses thereof |
| 01/07/2009 | EP2010151A2 Treatment of triple receptor negative breast cancer |
| 01/07/2009 | EP2010150A2 Stable emulsion formulations |
| 01/07/2009 | EP2010149A1 Nanostructured compositions having antibacterial, anti-fungal, anti-yeast, and/or anti-viral properties |
| 01/07/2009 | EP2010148A2 Composition including at least one aqueous phase and at least one fatty phase including ivermectin |
| 01/07/2009 | EP2010147A2 Non-covalent complexes of bioactive agents with starch for oral delivery |
| 01/07/2009 | EP2010146A1 Homeopathic composition and kit therefore |
| 01/07/2009 | EP2010145A2 Modification of percutaneous absorption of topically active materials |
| 01/07/2009 | EP2010144A2 Antioxidant compositions for reducing odor in warming lubricant compositions |
| 01/07/2009 | EP2010143A2 Stabilized ophthalmic compositions comprising oxidatively unstable components |
| 01/07/2009 | EP2010142A2 Polyesteramide platform for site specific drug delivery |
| 01/07/2009 | EP2010141A2 High-deposition compositions and uses thereof |
| 01/07/2009 | EP2010133A2 Foamable suspension gel |
| 01/07/2009 | EP1890681B1 Dry granulated composition comprising emtricitabine and tenofovir DF |
| 01/07/2009 | EP1729730B1 Tamper resistant dosage form comprising an adsorbent and an adverse agent |
| 01/07/2009 | EP1718568A4 Process for preparing water soluble diterpenes and their applications |
| 01/07/2009 | EP1699529B1 Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent |
| 01/07/2009 | EP1613396B1 Acoustic telemetry apparatus for intrabody communications |
| 01/07/2009 | EP1575597B1 Use of rimexolone in the treatment of dry eye |
| 01/07/2009 | EP1539101B1 Injectable multimodal polymer depot compositions and uses thereof |
| 01/07/2009 | EP1503737B1 Nanoparticulate nystatin formulations |
| 01/07/2009 | EP1499302A4 Fluid delivery device having an electrochemical pump with an anionic exchange membrane and associated method |
| 01/07/2009 | EP1499291B1 Methods and dosage forms for controlled delivery of oxycodone |
| 01/07/2009 | EP1496942B1 Microparticles comprising carbohydrate beads covalently linked with allergen derived from plant pollen |
| 01/07/2009 | EP1492511B1 Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s) |
| 01/07/2009 | EP1448253B1 Transdermal transport device with suction |
| 01/07/2009 | EP1341521B1 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 01/07/2009 | EP1251818B9 Galenic formulation |
| 01/07/2009 | EP1242103B1 Extracts derived from pueraria mirifica and extraction thereof |
| 01/07/2009 | EP1231895B1 Modular targeted liposomal delivery system |
| 01/07/2009 | EP1207936A4 Iontophoretic drug delivery device and reservoir and method of making same |
| 01/07/2009 | EP1170005B1 Use of sesquiterpene alcohol for regulating the autonomic nervous system |
| 01/07/2009 | EP0971693B1 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/07/2009 | CN101341371A Method of making dried particles |
| 01/07/2009 | CN101341119A Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure |
| 01/07/2009 | CN101340944A Device for controlled release of chemical molecules |
| 01/07/2009 | CN101340933A Factor xa inhibitor inclusion complex with cyclodextrin |
| 01/07/2009 | CN101340916A Preparation for external use having improved temporal stability of steroid |
| 01/07/2009 | CN101340900A Nanoscale particles used as contrasting agents in magnetic resonance imaging |
| 01/07/2009 | CN101340899A Orally disintegrating tablet comprising fat-soluble substance |
| 01/07/2009 | CN101340898A Multilayered chromonic structures |
| 01/07/2009 | CN101340897A Orally disintegrating tablet of lansoprazole |
| 01/07/2009 | CN101340896A Compressed solid dosage form containing low soluble medicament and preparation thereof |
| 01/07/2009 | CN101340895A Oral formulations comprising tigecycline |
| 01/07/2009 | CN101340894A Bursting pellets |
| 01/07/2009 | CN101340893A Intranasal administration of rapid acting insulin |
| 01/07/2009 | CN101340892A Use of a liquid allergy vaccine formulation for oromucosal administration |
| 01/07/2009 | CN101340882A Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol |
| 01/07/2009 | CN101338459A Method for preparing organic and inorganic nanometer assorted fibre |
| 01/07/2009 | CN101338045A Technique of preparing cassava starch plant gum, the plant gum prepared thereby and plant capsules |
| 01/07/2009 | CN101337067A Compound temperature sensitive type in-situ gel nasal-cavity administration preparation for treating osteoporosis |
| 01/07/2009 | CN101337066A Glutathion instant gel for eye |
| 01/07/2009 | CN101337064A Spray for treating nasal obstruction |
| 01/07/2009 | CN101337063A Drop pills for treating cardiac infarction |
| 01/07/2009 | CN101337061A Blood circulation promoting pain preventing plaster |
| 01/07/2009 | CN101337059A Plaster for treating hyperosteogeny and preparation method thereof |
| 01/07/2009 | CN101337057A Zhiqing granule and preparation method thereof |
| 01/07/2009 | CN101337053A Traditional Chinese medicine for treating pestilence and production method thereof |
| 01/07/2009 | CN101337049A Production method of pills for treating rheumatoid, rheumatism and infantile paralysis |
| 01/07/2009 | CN101337048A Medicine for treating hyperplasia of mammary glands |
| 01/07/2009 | CN101337047A Traditional Chinese medicine for treating hepatocirrhosis and hepatic ascites and production method thereof |
| 01/07/2009 | CN101337044A External preparation for mammary gland disease and preparation method thereof |
| 01/07/2009 | CN101337042A Rupixiaogao for treating hyperplasia of mammary glands |